D. E. Shaw & Co., Inc. National Research Corp Transaction History

D. E. Shaw & Co., Inc.

$122 Billion
Q4 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in National Research Corp stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 31,437 shares of NRC stock, worth $458,665. This represents 0.0% of its overall portfolio holdings.

Number of Shares

31,437

Previous 27,083 16.08%

Holding current value

$458,665

Previous $619,000 10.5%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$17.07 - $21.78 $74,322 - $94,830	4,354 Added 16.08%	31,437 $554,000
Q3 2024 Nov 14, 2024	SELL	$20.61 - $26.17 $191,302 - $242,909	-9,282 Reduced 25.52%	27,083 $619,000
Q2 2024 Aug 14, 2024	BUY	$22.95 - $39.34 $834,576 - $1.43 Million	36,365 New	36,365 $834,000
Q4 2023 Feb 14, 2024	BUY	$39.05 - $46.39 $798,650 - $948,768	20,452 New	20,452 $809,000
Q2 2022 Aug 15, 2022	SELL	$31.87 - $40.9 $169,835 - $217,956	-5,329 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$36.33 - $42.25 $193,602 - $225,150	5,329 New	5,329 $211,000
Q3 2020 Nov 16, 2020	SELL	$46.51 - $59.98 $269,804 - $347,943	-5,801 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$42.29 - $59.2 $12,687 - $17,760	-300 Reduced 4.92%	5,801 $338,000
Q1 2020 May 15, 2020	SELL	$35.01 - $70.35 $10,818 - $21,738	-309 Reduced 4.82%	6,101 $277,000
Q4 2019 Feb 14, 2020	SELL	$55.77 - $67.47 $33,573 - $40,616	-602 Reduced 8.59%	6,410 $423,000
Q3 2019 Nov 14, 2019	BUY	$55.58 - $67.42 $169,796 - $205,968	3,055 Added 77.2%	7,012 $405,000
Q2 2019 Aug 14, 2019	BUY	$38.52 - $57.59 $152,423 - $227,883	3,957 New	3,957 $228,000

Others Institutions Holding NRC

# of Institutions

140

Shares Held

12.5M

Call Options Held

600

Put Options Held

100

View Full List

About NATIONAL RESEARCH CORP

Ticker NRC
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 24,767,100
Market Cap $361M
Description
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-re...

More about NRC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account